title: Effect of cyclosporin A treatment on the enteropathy of graft-versus-host reaction in the rat: a quantitative study of intestinal morphology, epithelial cell kinetics and mucosal immune activity.
abstract: Mucosal graft-versus-host reaction (GvHR) of the small intestine exemplifies an immunologically mediated enteropathy that is associated with expansion of mucosal mast cells (MMC). Quantitative measures of intestinal morphology, epithelial cell kinetics and mucosal immune activity were used to assess the effect of the immunosuppressive agent, cyclosporin A (CyA), in ameliorating this enteropathy and on increased activity of MMC in the jejunum. GvHR was induced in two groups of PVGU x PVGC rats by irradiation (4.50 Gy) and intravenous injection of PVGC spleen cells (150 x 10(6)). One group remained untreated, while a second group of eight rats was treated with a 50 mg/kg dose of CyA subcutaneously given daily for the first 3 days and then every second day, and which had commenced the day before induction of GvHR. On day 14, all animals were killed. Treatment with CyA prevented intestinal crypt hyperplasia but did not affect villus length, and normalized the crypt cell production rate (CCPR) from 38 to 15 cells/crypt/h (P less than 0.0001). CyA reduced the number of MMC and jejunal content of the MMC associated protease, rat mucosal mast cell protease II (RMCPII). Mean serum RMCPII concentration was reduced from 302 (s.d. = 112) in GvHR animals to 10 (s.d. = 6) ng/mL in GvHR/CyA-treated rats (P less than 0.0001). We conclude that CyA ameliorates the enteropathy of GvHR and depresses the activation of MMC, as evident by the strongly depressed serum RMCPII concentration.
authors.affiliation: Gastro-Intestinal Unit, Western General Hospital, Edinburgh, Scotland, United Kingdom.
authors.forename: A G
authors.initials: AG
authors.lastname: Cummins
authors.forename: G H
authors.initials: GH
authors.lastname: Munro
authors.forename: H R
authors.initials: HR
authors.lastname: Miller
authors.forename: A
authors.initials: A
authors.lastname: Ferguson
mesh_terms: D000818:Animals; D003524:Cyclosporins / Q000627:therapeutic use*; D004848:Epithelium / Q000276:immunology; D006087:Graft vs Host Reaction / Q000187:drug effects*; D007413:Intestinal Mucosa / Q000276:immunology*; D007421:Intestine, Small / Q000276:immunology / Q000473:pathology; D008407:Mast Cells / Q000187:drug effects; D010447:Peptide Hydrolases / Q000097:blood; D051381:Rats; D011919:Rats, Inbred Strains; D013154:Spleen; D013601:T-Lymphocytes / Q000276:immunology
chemical_list: D003524:Cyclosporins; D010447:Peptide Hydrolases